Kei Miyamura

Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.

K Nanjo, Tokio Sanke, Motoshige Miyano et al. · Journal of Clinical Investigation · 1986 · 104 citations · Full text

Immunology, Pathology, Insulin Wakayama +18

Glucose intolerance in an employed population.

EIIOHI MIKUNI, Takashi Ohoshi, Kôji Hayashi et al. · The Tohoku Journal of Experimental Medicine · 1983 · 47 citations · Full text

Obesity, Nutrition, Metabolic Syndrome +15

Hemoglobin A1 in cirrhosis of the liver.

Yasuyuki Nomura, K Nanjo, Motoshige Miyano et al. · PubMed · 1989 · 35 citations

Pathology, Fatty Liver Disease, Lc Group +18

Insulin Wakayama: familial mutant insulin syndrome in Japan

K Nanjo, Motoshige Miyano, Mizuho Kondo et al. · Diabetologia · 1987 · 34 citations · Full text

Obesity, Metabolic Syndrome, Diabetes +6

Serum Type IV Collagen Concentrations in Diabetic Patients With Microangiopathy as Determined by Enzyme Immunoassay With Monoclonal Antibodies

Eisaku Matsumoto, Gensaku Matsumoto, Akira Ooshima et al. · Diabetes · 1990 · 28 citations

Immunology, Pathology, Diabetic Patients +20